Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy (Q84205357)
Jump to navigation
Jump to search
scientific article published on 24 May 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy |
scientific article published on 24 May 2012 |
Statements
Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy (English)
Solai Elango Damodaran
Suresh Chandra Pradhan
Gurusamy Umamaheswaran
Dharanipragada Kadambari
K Sathyanarayana Reddy
Chandrasekaran Adithan